United Therapeutics (UTHR) Approves $100M Buyback
Tweet Send to a FriendGet Alerts UTHR Hot Sheet
Up)
Trade UTHR Now!
United Therapeutics Corporation (Nasdaq: UTHR) approves a new $100 million share repurchase program.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Macy's (M) Posts Q1 EPS of 55c; Comps Up 3.8%; Boosts Dividend 25%, Raises Buyback
- Standpoint Research Downgrades United Therapeutics Corp. (UTHR) to Hold
- Agilent (A) Tops Q2 EPS by 9c, Trims FY13 Outlook; Adds to Buyback, Will Cut Jobs
Create E-mail Alert Related Categories
Stock BuybacksRelated Entities
Stock Buyback
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
